| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |